UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLGO
4776
MicroAlgo
MLGO
$45.6M
| $1.86M | ﹤0.01% |
16,479
+16,216
| +6,166% | +$2.05M |
|
4777
Andersons Inc
ANDE
$2.22B
| $1.85M | ﹤0.01% |
45,757
+7,128
| +18% | +$331K |
|
|
BCYC
4778
Bicycle Therapeutics
BCYC
$292M
| $1.85M | ﹤0.01% |
132,361
+120,295
| +997% | +$2.58M |
|
4779
PUT
Wolfspeed
WOLF
$1.71B
| $1.85M | ﹤0.01% |
277,900
+143,800
| +107% | +$1.47M |
|
4780
Oculis Holding
OCS
$704M
| $1.85M | ﹤0.01% |
108,842
+91,065
| +512% | +$1.43M |
|
4781
Banco de Chile
BCH
$20.9B
| $1.85M | ﹤0.01% |
81,565
+49,225
| +152% | +$1.16M |
|
4782
VanEck Green Bond ETF
GRNB
$185M
| $1.85M | ﹤0.01% |
78,050
-3,942
| -5% | -$94.8K |
|
4783
CALL
Gold Fields
GFI
$36.5B
| $1.85M | ﹤0.01% |
140,000
+40,000
| +40% | +$609K |
|
4784
CALL
Sibanye-Stillwater
SBSW
$7.53B
| $1.85M | ﹤0.01% |
560,000
+514,800
| +1,139% | +$2.17M |
|
4785
Anterix
ATEX
$1.94B
| $1.85M | ﹤0.01% |
60,228
+53,569
| +804% | +$1.78M |
|
4786
PUT
Trane Technologies
TT
$106B
| $1.85M | ﹤0.01% |
+5,000
| New | +$1.98M |
|
4787
Perella Weinberg Partners
PWP
$1.3B
| $1.84M | ﹤0.01% |
77,337
+32,279
| +72% | +$749K |
|
|
DENN
4788
DELISTED
Denny's
DENN
| $1.84M | ﹤0.01% |
304,063
+270,484
| +806% | +$1.72M |
|
4789
Rackspace Technology
RXT
$1.24B
| $1.84M | ﹤0.01% |
831,667
+793,637
| +2,087% | +$2M |
|
4790
Nicolet Bankshares
NIC
$3.62B
| $1.84M | ﹤0.01% |
17,509
+8,570
| +96% | +$905K |
|
4791
Climb Global Solutions
CLMB
$519M
| $1.84M | ﹤0.01% |
57,968
+42,784
| +282% | +$1.27M |
|
4792
TaskUs
TASK
$669M
| $1.83M | ﹤0.01% |
108,248
+38,426
| +55% | +$551K |
|
|
GRSD
4793
Grandstand Limited Ordinary Shares
GRSD
$67M
| $1.83M | ﹤0.01% |
130,130
+115,015
| +761% | +$1.35M |
|
4794
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
| $1.83M | ﹤0.01% |
23,885
+336
| +1% | +$26.3K |
|
|
AVNS
4795
DELISTED
Avanos Medical
AVNS
| $1.83M | ﹤0.01% |
114,876
+12,705
| +12% | +$251K |
|
4796
Nuveen ESG US Aggregate Bond ETF
NUBD
$466M
| $1.83M | ﹤0.01% |
83,900
-1,128
| -1% | -$24.9K |
|
4797
Perspective Therapeutics
CATX
$342M
| $1.82M | ﹤0.01% |
571,748
+485,362
| +562% | +$3.96M |
|
4798
PUT
Huntington Bancshares
HBAN
$35.5B
| $1.82M | ﹤0.01% |
112,100
| – | – |
|
|
ACH
4799
Accendra Health
ACH
$214M
| $1.82M | ﹤0.01% |
139,501
+55,894
| +67% | +$745K |
|
4800
PUT
Freshpet
FRPT
$3.22B
| $1.82M | ﹤0.01% |
12,300
| – | – |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.